Related Experiment Video
Updated: Jun 14, 2026
13:59
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
Published on: August 18, 2023
Cytotoxicity of Atriplex confertifolia
Christopher J Capua1, Nick P Hopson, C Malcolm M Stewart
1Department of Plant and Wildlife Science, Brigham Young University, 275 Widtsoe Building, Provo, UT 84602, USA.
Journal of Toxicology
|March 27, 2010
Summary
Extracts from the North American plant Atriplex confertifolia show significant anticancer activity against breast and cervical cancer cell lines. The plant
Area of Science:
- Phytochemistry
- Pharmacology
- Oncology
Background:
- Natural products are a vital source for novel cancer treatments.
- Many plant-derived compounds are being investigated for their cytotoxic effects on cancer cells.
- Atriplex confertifolia, a native North American plant, has not been extensively studied for its medicinal properties.
Purpose of the Study:
- To investigate the anticancer bioactivity of Atriplex confertifolia extracts against human cancer cell lines.
- To compare the efficacy of A. confertifolia extracts with a standard chemotherapy drug and a control cell line.
- To identify the active fractions and understand the mechanism of cell death induced by the extracts.
Main Methods:
- Preparation and fractionation of Atriplex confertifolia extracts.
- In vitro testing of extracts against human breast cancer (MCF-7, MDA-MB 435, MDA-MB 231) and cervical cancer (HeLa) cell lines.
- Cytotoxicity assays and dose-response curve analysis.
- Comparison with Onxol((R)) (paclitaxel) and a leukocyte control cell line.
- Apoptosis assays to determine the mode of cell death.
Main Results:
- Polar fractions of A. confertifolia extracts exhibited significant cytotoxic activity against tested cancer cell lines.
- The plant extracts demonstrated comparable dose-dependent cell death to Onxol((R)).
- No significant inhibition of viability was observed in the leukocyte control cell line.
- Over 90% cell death was recorded in MDA-MB 435 and HeLa cells within 24 hours.
- Evidence suggests that cell death is induced via apoptosis.
Conclusions:
- Atriplex confertifolia possesses potent anticancer properties against human breast and cervical cancer cells.
- The plant extracts offer a promising natural alternative or adjunct therapy for cancer treatment.
- Further research into the specific compounds and mechanisms of A. confertifolia is warranted for drug development.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...